Immatics N.V.
IMTX
$5.10
-$0.13-2.49%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/4/2025
-
MarketBeat
5/3/2025
-
Tickeron - Stocks
4/30/2025
-
Bizjournals.com - Health Care News
4/24/2025
-
Tickeron - Technical Analysis
4/23/2025
-
Globe Newswire
4/20/2025
-
MarketBeat
4/19/2025
-
MarketBeat
4/18/2025
-
MarketBeat
4/18/2025
-
Tickeron - Stocks
4/16/2025
-
MarketBeat
4/16/2025
-
Yahoo! Finance: News
4/16/2025
-
Insider Monkey
4/16/2025
-
Tickeron - Stocks
4/15/2025
-
Insider Monkey
4/15/2025
-
Tickeron - Stocks
4/15/2025
-
MarketBeat
4/10/2025
-
Tickeron - Stocks
4/9/2025
-
Tickeron - Technical Analysis
4/8/2025
-
Tickeron - Stocks
4/5/2025
-
Tickeron - Technical Analysis
4/5/2025
-
Tickeron - Technical Analysis
4/5/2025
-
MarketBeat
4/4/2025
-
Ticker Report
4/4/2025
-
MarketBeat
4/3/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
49 7071 5397 0
Address
Paul-Ehrlich-Strasse 15
Tübingen, 72076
Tübingen, 72076
Country
Year Founded
--
Business Description
Sector
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United...
more